Lepra familiar

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Fluorescein in Lepra Reaction

were first recorded in India, by the present writers in Rao and Ray (1932). Since then, other workers, notable among them being Muir and Chatterjee (1932 and 1933) and Chatterjee (1933), have-attempted to study the action of Mercurochrome as well as that of one of its constituents, viz, fluorescein, in leprosy. Ryrie (1934) has further continued to study the influence of fluorescein on ' lepra ...

متن کامل

The Origin of the Lepra

One of the most striking features of the anatomical changes which develop in leprosy is the occurrence in the lesion of great numbers of large phagocytic cells filled with bacilli. These cells were first noted by Virchow, I and were given the name of "lepta cells" by him. Later investigation has shown that they are characteristic of the disease, the leprous nodule being composed almost entirely...

متن کامل

Effects of Lepra Reaction in Lepromatous Leprosy £;

In 1936 I was a joint author of an article [Rev. brasileira L eprol. 4 (1936) 129] in which it was asserted that: (a) lepra reaction is beneficial because it impedes the progress of the disease and improves the skin lesions; and (b) in such cases ocular lesions are less frequent than in those which never had reaction. In 1947 I reported [Rev. argentina Dermatosi f. 31 (1947) 506] that (a ) lepr...

متن کامل

The Origin of the Lepra Cell

1. By means of the method of vital staining it is found that the lepra cell in rat leprosy is derived from the histiocyte. 2. From the similarity in morphology and function of the lepra cells in this condition and those of human leprosy, it seems likely that derivation of the cells in the two conditions is similar.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Biomédica

سال: 2001

ISSN: 0120-4157

DOI: 10.7705/biomedica.v21i3.1115